138 related articles for article (PubMed ID: 6324457)
61. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
62. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
63. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
Cho MS; Fresen KO; zur Hausen H
Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
[TBL] [Abstract][Full Text] [Related]
64. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
Casareale D; Jones W; Sairenji T; Humphreys RE
Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
[TBL] [Abstract][Full Text] [Related]
65. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
[TBL] [Abstract][Full Text] [Related]
66. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
Moar MH; Klein G
Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
[TBL] [Abstract][Full Text] [Related]
67. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen.
Fox R; Sportsman R; Rhodes G; Luka J; Pearson G; Vaughan J
J Clin Invest; 1986 May; 77(5):1539-47. PubMed ID: 2422209
[TBL] [Abstract][Full Text] [Related]
68. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
[TBL] [Abstract][Full Text] [Related]
69. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
70. Studies on Epstein-Barr virus-related antigens. II. Biochemical properties of soluble antigen in Raji Burkitt lymphoma cells.
Matsuo T; Nishi S; Hirai H; Osato T
Int J Cancer; 1977 Mar; 19(3):364-70. PubMed ID: 14897
[TBL] [Abstract][Full Text] [Related]
71. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
72. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
73. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
Hilgers F; Rosén A; Lamon E; Klein G
J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
[No Abstract] [Full Text] [Related]
74. Immunochemical characterization of EBV antigens detected by double immunodiffusion.
Sternås L; Kallin B; Luka J; Klein G
Intervirology; 1982; 17(4):208-14. PubMed ID: 6182123
[TBL] [Abstract][Full Text] [Related]
75. Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes.
Lin JC; Pagano JS
J Virol; 1986 Aug; 59(2):522-4. PubMed ID: 3016315
[TBL] [Abstract][Full Text] [Related]
76. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
Yamamoto K; Osato T
Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
[TBL] [Abstract][Full Text] [Related]
77. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
78. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
[TBL] [Abstract][Full Text] [Related]
79. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.
Kallin B; Luka J; Klein G
J Virol; 1979 Dec; 32(3):710-6. PubMed ID: 229261
[TBL] [Abstract][Full Text] [Related]
80. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains.
Georg-Fries B; Mueller-Lantzsch N
Med Microbiol Immunol; 1982; 171(1):11-21. PubMed ID: 6289060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
